University of Oxford
Oxford, Oxfordshire, United Kingdom
Purpose
to improve the performance of human immunodeficiency virus type-1 (HIV-1) envelope glycoprotein (Env) vaccine antigens by using chemical cross-linking strategies to enhance the antigenicity and stability of soluble, next-generation Env.
Division
Global Health
Date
September 2014
Region Served
GLOBAL
Committed amount
$351,146
Grant topic
Discovery and Translational Sciences
Duration (months)
25
Grantee location
Oxford, Oxfordshire, United Kingdom
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.